Germany· DE-A57-1e357d59385c03ce
Ibandronsäure Stada
A ibandronic acid product containing ibandronic acid, registered in Germany by Stadapharm Gmbh. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Ibandronic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC M05BA06 (ibandronic acid), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Ibandronic acid · ATC M05BA06
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ibandronic acid costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.089 in United States to $1.30 in Switzerland — a ×15 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ibandronic acid · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.30
- ES Spain$0.49
- IT Italy$0.38
- US United States$0.089 (acquisition cost)
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ibandronic Acid
- Manufacturer
- Stadapharm Gmbh
- Country
- Germany (DE)
- ATC code
- M05BA06
- ATC class
- Ibandronic acid
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
228 interactions on record for ibandronic acid.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ibandronic acid · interactions on record
228 records
- 12 severe
- 98 moderate
- 94 info
Most severe, free to view
- EtelcalcetideH05BX04severe
- SirolimusL01EG04severe
- SirolimusL04AA10severe
- TacrolimusL04AD02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ibandronic acid in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBondronat 2mg/2ml concentrate for solution for infusion vialsAtnahs Pharma UK Ltd
- NetherlandsBaxogar 150 mg filmomhulde tablettenPharmathen S.A.
- SpainABRION 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEspecialidades Farmaceuticas Centrum S.A.
- PolandBondronatAtnahs Pharma Netherlands B.V.
- ItalyACIDO IBANDRONICO ALTERLABORATORI ALTER S.R.L.
- SwedenBondronat 2 mg Koncentrat till infusionsvätska, lösningAtnahs Pharma Netherlands B.V.
- IcelandBondronatAtnahs Pharma Netherlands B.V.
- IrelandBondronat 2 mg concentrate for solution for infusion.Atnahs Pharma Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Ibandronsäure Ratiopharm, Ibandronsäure Sandoz
- Belgium · Ibandronate Eg
- Bulgaria · Ибандронова Киселина Синтон, Ибандронова Киселина Стада
- Czechia · Gerousia, Ikametin
- Denmark · Baxogar, Ibamyl
- Estonia · Bonefurbit, Ibandronic Acid Synthon
- Spain · Abrion, Ácido Ibandrónico Alter
- Finland · Clastec, Ibandronat Stada
- United Kingdom (Northern Ireland) · Bondronat, Ibandronic Acid
- Greece · Axibal, Ibanate
- Croatia · Bonnedra, Bonosta
- Hungary · Ibandronate Pharmacenter, Ibandronsav Stada
- Ireland · Ibandronic Acid Accord Healthcare Ireland, Ibandronic Acid Clonmel
- Iceland · Ibandronic Acid Accord, Ibandronic Acid Alvogen
- Italy · Acido Ibandronico Alter, Acido Ibandronico Aurobindo
- Liechtenstein · Ibandronic Acid Accord, Ibandronic Acid Teva
- Lithuania · Bonefurbit, Ibandronic Acid Ingen Pharma
- Luxembourg · Ibandronate Eg
- Latvia · Ibandronic Acid Ratiopharm, Ibandronic Acid Synthon
- Malta · Ibandronic Acid Aurobindo
- Netherlands · Baxogar, Ibandronic Acid Aurobindo
- Norway · Axibal, Bonefurbit
- Poland · Ibandronic Acid Aurovitas, Ibandronic Acid Synthon
- Portugal · Ácido Ibandrónico Alter, Ácido Ibandrónico Aurobindo
- Romania · Acid Ibandronic Stada
- Sweden · Ibandronat Stada
- Slovenia · Ibandronska Kislina Synthon
- Slovakia · Gerousia, Ibandronic Acid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b13cb280-811a-4421-a6ab-e2f019aacf0a GET /v1/drugs/b13cb280-811a-4421-a6ab-e2f019aacf0a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ibandronic Acid",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ibandronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.